medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2022-25-26-33medalphabet-2854Research ArticleСтатьиРоль экзогенного мелатонина в регуляции снаThe role of exogenous melatonin in the regulation of sleephttps://orcid.org/0000-0002-4689-3591ОрловаС. В.OrlovaS. V.

Орлова Светлана Владимировна, доктор медицинских наук, профессор, заведующая кафедрой диетологии и клинической нутрициологии

Москва 

Orlova Svetlana V., DM Sci (habil.), professor, head of Dept of Dietetics and Clinical Nutritiology

Moscow 

orlova-sv@rudn.ruhttps://orcid.org/0000-0003-3220-0333НикитинаЕ. А.NikitinaE. A.

Никитина Елена Александровна, кандидат медицинских наук, доцент кафедры диетологии и клинической нутрициологии

Москва

Nikitina Elena A., PhD Med, assistant professor at Dept of Dietetics and Clinical Nutritiology

Moscow

nikitina-ea1@rudn.ruhttps://orcid.org/0000-0002-0548-3414БалашоваН. В.BalashovaN. V.

Балашова Наталья Валерьевна, кандидат медицинских наук, ассистент кафедры диетологии и клинической нутрициологии

Москва 

SPIN: 2355–6837,

Author ID: 832745

Balashova Natalya V., PhD Bio, assistant at Dept of Dietetics and Clinical Nutritiology

Moscow

SPIN: 2355–6837,

Author ID: 832745

BalashovaN77@mail.ruhttps://orcid.org/0000-0003-4749-731XПигареваЮ. А.PigarevaYu. A.

Пигарева Юлия Анатольевна, кандидат медицинских наук, заведующая отделением клинической диетологии

Москва

Pigareva Yulia A., PhD Med, head of Dept of Clinical Dietetics

Moscow

1092153068@rudn.ruhttps://orcid.org/0000-0003-3021-5208АнквабЭ. В.AnkvabE. V.

Анкваб Эсма Витальевна, студентка 6-го курса лечебного дела медицинского факультета

Москва

Ankvab Esma V., 6th year medical student of the Faculty of Medicine

Moscow

https://orcid.org/0000-0001-9897-9293ХаджимуратоваТ. И.KhadzhimuratovaT. I.

Хаджимуратова Тоита Ильясовна, студентка 6-го курса лечебного дела медицинского факультета

Москва

Khadzhimuratova Toita I., 6th year medical student of the Faculty of Medicine

Moscow

ФГАОУ ВО «Российский университет дружбы народов»РоссияPeoples’ Friendship University of RussiaRussian FederationГБУЗ «Городская клиническая больница имени В.В. Виноградова Департамента здравоохранения Москвы»РоссияCity Clinical Hospital n.a. V.V. VinogradovRussian Federation202225112022025Современная поликлиника (2)2633Copyright © Орлова С.В., Никитина Е.А., Балашова Н.В., Пигарева Ю.А., Анкваб Э.В., Хаджимуратова Т.И., 20222022Орлова С.В., Никитина Е.А., Балашова Н.В., Пигарева Ю.А., Анкваб Э.В., Хаджимуратова Т.И.Orlova S.V., Nikitina E.A., Balashova N.V., Pigareva Y.A., Ankvab E.V., Khadzhimuratova T.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2854

Мелатонин – естественный гормон, вырабатываемый эпифизом, является производным серотонина. Одним из ключевых свойств мелатонина является его хронобиологическая способность, реализуемая многоуровневой синхронизацией биологических процессов. Физиологически секреция мелатонина повышается при наступлении темноты и снижается утром. В настоящее время доказана роль мелатонина в регуляции сна, циркадных ритмов, адаптации организма к быстрой смене часовых поясов. При снижении выработки эндогенного мелатонина у ряда людей (при расстройстве суточных биоритмов в связи с дальним перелетом, сменной работе, бессоннице) применение экзогенного мелатонина улучшает качество сна.

Melatonin is a natural hormone produced by the pineal gland and is a derivative of serotonin. One of the key properties of melatonin is its chronobiological ability, realized by multilevel synchronization of biological processes. Physiologically, melatonin secretion increases at night and decreases in the morning. At present, the role of melatonin in the regulation of sleep, circadian rhythms, and adaptation of the body to a rapid change in time zones has been proven. With a decrease in the production of endogenous melatonin in a number of people (with a disorder of daily biorhythms due to long-distance flights, shift work, insomnia), the use of exogenous melatonin improves the quality of sleep.

мелатонинхронобиологияциркадность ритмабиоритмыдепривация снабессонница (инсомния)режим снасменная работадлительные перелетынейродегенеративные заболеванияmelatoninchronobiologycircadian rhythmbiorhythmssleep deprivationinsomnia (insomnia)sleep patternshift worklong flightsneurodegenerative diseasesReferencesSateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J. Clin. Sleep. Med. 2017 Feb 15;13(2):307–349. DOI: 10.5664/jcsm.6470Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J. Clin. Sleep. Med. 2017 Feb 15;13(2):307–349. DOI: 10.5664/jcsm.6470Захаров А.В., Хивинцева Е.В. Клиническое применение мелатонина в терапии расстройств сна // Эффективная фармакотерапия. 2019. Т. 15. № 44. С. 42–47. DOI 10.33978/2307–3586–2019–15–44–42–47Zakharov A. V., Khivintseva E. V. Clinical Use of Melatonin in the Treatment of Sleep Disorders. Effective pharmacotherapy. 2019. V. 15. No. 44. P. 42–47. DOI 10.33978/2307–3586–2019–15–44–42–47Полуэктов М.Г. Современные представления о природе и методах лечения инсомнии // Российский физиологический журнал им. И.М. Сеченова. 2012. Т. 98. № 10. С. 1188–1199.Poluektov MG. [Origin and treatment of insomnia: current status of knowledge]. Ross Fiziol Zh Im I M Sechenova. 2012 Oct;98(10):1188–99. Russian. PMID: 23401914.Оганесян Г. А., Аристакесян Е. А., Романова И. В., Ватаев С. И., Кузик В. В., Камбарова Д. К. Вопросы эволюции цикла бодрствование-сон. Часть 2: нейромедиаторные механизмы регуляции // Биосфера. 2013. № 1. С. 97–123. URL: https://cyberleninka.ru/article/n/voprosy-evolyutsii-tsikla-bodrstvovanie-sonchast 2-neyromediatornye-mehanizmy-regulyatsii (дата обращения: 17.11.2022).Oganesyan G.A., Aristakesyan Ye.A., Romanova I.V., Vatayev S.I., Kuzik V.V., Kambarova D.K. Evolutionary aspects of the slep-wakefulness cycle. Part 2: Neuromediator mechanisms of its regulation. Biosfera. 2011. Vol. 5. No. 1. 97–123. URL: https://cyberleninka.ru/article/n/voprosy-evolyutsii-tsikla-bodrstvovanie-son-chast2-neyromediatornye-mehanizmy-regulyatsii (дата обращения: 17.11.2022).Бурчинский С.Г. Мелатонин и его возможности в клинической практике // Мелатонин: перспективы применения в клинике / под ред. С.И. Рапопорта. М.: ИМА-ПРЕСС, 2012. 176 с., Рапопорт С.И. Хрономедицина, циркадианные ритмы. Кому это нужно? // Клиническая медицина. 2012. № 8. С. 73–75.Burchinsky S.G. Melatonin and its possibilities in clinical practice. Melatonin: prospects for clinical use / ed. S.I. Rapoport. Clinical medicine. 2012. No. 8. pp. 73–75.Tan D.X., Hardeland R., Back K., Manchester L.C., Alatorre-Jimenez M.A., Reiter R.J. On the significance of an alternate pathway of melatonin synthesis via 5-methoxytryptamine: Comparisons across species. J. Pineal Res. 2016;61:27–40. DOI: 10.1111/jpi.12336Tan D.X., Hardeland R., Back K., Manchester L.C., Alatorre-Jimenez M.A., Reiter R.J. On the significance of an alternate pathway of melatonin synthesis via 5-methoxytryptamine: Comparisons across species. J. Pineal Res. 2016;61:27–40. DOI: 10.1111/jpi.12336Lerner A.B., Case J.D., Takahashi Y., Lee T., Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocytes J. Am. chem. Soc. 80, 2587 (1958). DOI:10.1021/ja01543a060Lerner A.B., Case J.D., Takahashi Y., Lee T., Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocytes J. Am. chem. Soc. 80, 2587 (1958). DOI:10.1021/ja01543a060Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med. Rev. 2017 Aug;34:10–22. DOI: 10.1016/j.smrv.2016.06.005Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med. Rev. 2017 Aug;34:10–22. DOI: 10.1016/j.smrv.2016.06.005Zimmermann RC, McDougle CJ, Schumacher M, Olcese J, Mason JW, Heninger GR, Price LH. Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. J. Clin. Endocrinol. Metab. 1993 May;76(5):1160–4. DOI: 10.1210/jcem.76.5.8496306Zimmermann RC, McDougle CJ, Schumacher M, Olcese J, Mason JW, Heninger GR, Price LH. Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. J. Clin. Endocrinol. Metab. 1993 May;76(5):1160–4. DOI: 10.1210/jcem.76.5.8496306Billyard AJ, Eggett DL, Franz KB. Dietary magnesium deficiency decreases plasma melatonin in rats. Magnes Res. 2006 Sep;19(3):157–61. PMID: 17172005.Billyard AJ, Eggett DL, Franz KB. Dietary magnesium deficiency decreases plasma melatonin in rats. Magnes Res. 2006 Sep;19(3):157–61. PMID: 17172005.Claustrat B, Leston J. Melatonin: Physiological effects in humans. Neurochirurgie. 2015 Apr-Jun;61(2–3):77–84. DOI: 10.1016/j.neuchi.2015.03.002.Claustrat B, Leston J. Melatonin: Physiological effects in humans. Neurochirurgie. 2015 Apr-Jun;61(2–3):77–84. DOI: 10.1016/j.neuchi.2015.03.002.Леваков С., Боровкова Е. Физиологическая роль и клинические эффекты мелатонина // Врач. 2015. № 3. 72–75. URL: https://cyberleninka.ru/article/n/fiziologicheskaya-rol-i-klinicheskie-effekty-melatonina (дата обращения: 16.11.2022).Levakov S., Borovkova E. Melatonin: physiological role and clinical effects. Vrach (The Doctor). 2015;(3):72–75. https://vrachjournal.ru/ru/25877305–2015–03–19.Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol. Rev. 2010 Sep;62(3):343–80. DOI: 10.1124/pr.110.002832Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol. Rev. 2010 Sep;62(3):343–80. DOI: 10.1124/pr.110.002832Ma H, Kang J, Fan W, He H, Huang F. ROR: Nuclear Receptor for Melatonin or Not? Molecules. 2021 May 4;26(9):2693. DOI: 10.3390/molecules26092693Ma H, Kang J, Fan W, He H, Huang F. ROR: Nuclear Receptor for Melatonin or Not? Molecules. 2021 May 4;26(9):2693. DOI: 10.3390/molecules26092693Socaciu A.I., Ionuţ R., Socaciu M.A., Ungur A.P., Bârsan M., Chiorean A., Socaciu C., Râjnoveanu A.G. Melatonin, an ubiquitous metabolic regulator: Functions, mechanisms, and effects on circadian disruption and degenerative diseases. Rev. Endocr. Metab. Disord. 2020;21:465–478. DOI: 10.1007/s11154–020–09570–9Socaciu A.I., Ionuţ R., Socaciu M.A., Ungur A.P., Bârsan M., Chiorean A., Socaciu C., Râjnoveanu A.G. Melatonin, an ubiquitous metabolic regulator: Functions, mechanisms, and effects on circadian disruption and degenerative diseases. Rev. Endocr. Metab. Disord. 2020;21:465–478. DOI: 10.1007/s11154–020–09570–9Ma N., Zhang J., Reiter R. J., Ma X. Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation. Med. Res. Rev. 2020;40:606–632. DOI: 10.1002/med.21628Ma N., Zhang J., Reiter R. J., Ma X. Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation. Med. Res. Rev. 2020;40:606–632. DOI: 10.1002/med.21628Owino S., Buonfiglio D., Tchio C., Tosini G. Melatonin signaling a key regulator of glucose homeostasis and energy metabolism. Front. Endocrinol. 2019;10:488. DOI: 10.3389/fendo.2019.00488Owino S., Buonfiglio D., Tchio C., Tosini G. Melatonin signaling a key regulator of glucose homeostasis and energy metabolism. Front. Endocrinol. 2019;10:488. DOI: 10.3389/fendo.2019.00488Bu S., Wang Q., Sun J., Li X., Gu T., Lai D. Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE/AKT/β-catenin/SLUG axis. Cell Death Dis. 2020;11:644. DOI: 10.1038/s41419–020–02906-yBu S., Wang Q., Sun J., Li X., Gu T., Lai D. Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE/AKT/β-catenin/SLUG axis. Cell Death Dis. 2020;11:644. DOI: 10.1038/s41419–020–02906-yЦветкова Е.С., Романцова Т.И., Полуэктов М.Г., Рунова Г.Е., Глинкина И.В., Фадеев В.В. Значение мелатонина в регуляции метаболизма, пищевого поведения, сна и перспективы его применения при экзогенно-конституциональном ожирении // Ожирение и метаболизм. 2021. № 2. 112–124. URL: https://cyberleninka.ru/article/n/znachenie-melatonina-v-regulyatsii-metabolizma-pischevogo-povedeniyasna-i-perspektivy-ego-primeneniya-pri-ekzogenno (дата обращения: 16.11.2022).Tsvetkova ES, Romantsova TI, Poluektov MG, Runova GE, Glinkina IV, Fadeev VV. The importance of melatonin in the regulation of metabolism, eating behavior, sleep, and the prospects for the use of melatonin drugs for obesity treatment. Obesity and metabolism. 2021;18(2):112–124. doi: https://doi.org/10.14341/omet12279Hardeland R., Madrid J.A., Tan D.X., Reiter R.J. Melatonin, the circadian multioscillator system, and health: The need for detailed analyses of peripheral melatonin signaling. J. Pineal Res. 2012;52:139–166. DOI: 10.1111/j.1600–079X.2011.00934.xHardeland R., Madrid J.A., Tan D.X., Reiter R.J. Melatonin, the circadian multioscillator system, and health: The need for detailed analyses of peripheral melatonin signaling. J. Pineal Res. 2012;52:139–166. DOI: 10.1111/j.1600–079X.2011.00934.xМетаболизм индоламинов. Chromolab.ru.Metabolism of indolamines. Chromolab.ruAdan A., Archer S.N., Hidalgo M.P., Di Milia L., Natale V., Randler C. Circadian Typology: A Comprehensive Review. Chronobiol. Int. 2012;29(9):1153–1175. https://doi.org/10.3109/07420528.2012.719971.Adan A., Archer S.N., Hidalgo M.P., Di Milia L., Natale V., Randler C. Circadian Typology: A Comprehensive Review. Chronobiol. Int. 2012;29(9):1153–1175. https://doi.org/10.3109/07420528.2012.719971.Cohen Engler A, Hadash A, Shehadeh N, Pillar G. Breastfeeding may improve nocturnal sleep and reduce infantile colic: potential role of breast milk melatonin. Eur. J. Pediatr. 2012;171(4):729–732. DOI: 10.1007/s00431–011–1659–3Cohen Engler A, Hadash A, Shehadeh N, Pillar G. Breastfeeding may improve nocturnal sleep and reduce infantile colic: potential role of breast milk melatonin. Eur. J. Pediatr. 2012;171(4):729–732. DOI: 10.1007/s00431–011–1659–3Cubero J, Valero V, Sánchez J, Rivero M, Parvez H, Rodríguez AB, Barriga C. The circadian rhythm of tryptophan in breast milk affects the rhythms of 6-sulfatoxymelatonin and sleep in newborn. Neuro Endocrinol. Lett. 2005 Dec;26(6):657–61. PMID: 16380706.Cubero J, Valero V, Sánchez J, Rivero M, Parvez H, Rodríguez AB, Barriga C. The circadian rhythm of tryptophan in breast milk affects the rhythms of 6-sulfatoxymelatonin and sleep in newborn. Neuro Endocrinol. Lett. 2005 Dec;26(6):657–61. PMID: 16380706.Bubenik GA, Konturek SJ. Melatonin and aging: prospects for human treatment. J. Physiol. Pharmacol. 2011 Feb;62(1):13–9. PMID: 21451205.Bubenik GA, Konturek SJ. Melatonin and aging: prospects for human treatment. J. Physiol. Pharmacol. 2011 Feb;62(1):13–9. PMID: 21451205.Waldhauser F, Weiszenbacher G, Frisch H, Zeitlhuber U, Waldhauser M, Wurtman RJ. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet. 1984 Feb 18;1(8373):362–5. DOI: 10.1016/s0140–6736(84)90412–4Waldhauser F, Weiszenbacher G, Frisch H, Zeitlhuber U, Waldhauser M, Wurtman RJ. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet. 1984 Feb 18;1(8373):362–5. DOI: 10.1016/s0140–6736(84)90412–4Рапопорт С.И. Хрономедицина, циркадианные ритмы. Кому это нужно? // Клиническая медицина. 2012. № 8. С. 73–75.Rapoport S.I. Chronomedicine, circadian rhythms. Who needs it? // Clinical medicine. 2012. No. 8. P. 73–75.Zisapel N. Drugs for insomnia. Expert Opin Emerg Drugs. 2012 Sep;17(3):299–317. DOI: 10.1517/14728214.2012.690735Zisapel N. Drugs for insomnia. Expert Opin Emerg Drugs. 2012 Sep;17(3):299–317. DOI: 10.1517/14728214.2012.690735Pierpaoli W., Bulian D., Bulian G., Kistler G. Thyrotropin-Releasing Hormone Accelerates and Enhances the Age-Postponing Effects of Melatonin. Journal of Anti-Aging Medicine. Jan 1999.343–348. DOI:10.1089/rej.1.1999.2.343Pierpaoli W., Bulian D., Bulian G., Kistler G. Thyrotropin-Releasing Hormone Accelerates and Enhances the Age-Postponing Effects of Melatonin. Journal of Anti-Aging Medicine. Jan 1999.343–348. DOI:10.1089/rej.1.1999.2.343Забелина В.Д. Мелатонин – «гормон сна» и не только // Consilium provisorum. 2006. № 3. С. 9–12.Zabelina V.D. Melatonin – «sleep hormone» and not only // Consilium provisorum. 2006. No. 3. S. 9–12.Ляшенко Е. А., Левин О. С. Расстройства сна в клинической практике // Современная терапия в психиатрии и неврологии. 2017. № 1. 22–28. URL: https://cyberleninka.ru/article/n/rasstroystva-sna-v-klinicheskoy-praktike (дата обращения: 16.11.2022).Lyashenko E. A., Levin O. S. Sleep disorders in clinical practice. Handbook for Practitioners Doctors. 2017; 4: 57–61. https://omnidoctor.ru/library/izdaniya-dlyavrachey/spravochnik-poliklinicheskogo-vracha/spv2017/spv2017_4/rasstroystvasna-v-klinicheskoy-praktike/Зыбина Н.Н., Тихомирова О.В. Нарушение секреции мелатонина и эффективность заместительной терапии при расстройствах сна. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2018;118(4–2):92–98. https://doi.org/10.17116/jnevro20181184292Zybina NN, Tikhomirova OV. Disturbances in melatonin secretion and the efficacy of replacement therapy in sleep disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018;118(4–2):92–98 (in Russ.). https://doi.org/10.17116/jnevro20181184292Стрыгин К.Н., Полуэктов М.Г., Левин Я.И. Формы инсомнии и возможности ее медикаментозного лечения // Эффективная фармакотерапия. 2012. № 3. С. 38–43. https://umedp.ru/articles/formy_insomnii_i_vozmozhnosti_ee_medikamentoznogo_lecheniya.htmlStrygin K.N., Poluektov M.G., Levin Ya.I. Forms of insomnia and the possibility of its drug treatment // Effective pharmacotherapy. 2012. No. 3. S. 38–43. https://umedp.ru/articles/formy_insomnii_i_vozmozhnosti_ee_medikamentoznogo_lecheniya.htmlCappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur. Heart. J. 2011 Jun;32(12):1484–92. DOI: 10.1093/eurheartj/ehr007Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur. Heart. J. 2011 Jun;32(12):1484–92. DOI: 10.1093/eurheartj/ehr007Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010 Feb;33(2):414–20. DOI: 10.2337/dc09–1124Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010 Feb;33(2):414–20. DOI: 10.2337/dc09–1124Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab. Syndr. Obes. 2011;4:307–13. DOI: 10.2147/DMSO.S23904.Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab. Syndr. Obes. 2011;4:307–13. DOI: 10.2147/DMSO.S23904.Buysse DJ. Insomnia. JAMA. 2013 Feb 20;309(7):706–16. DOI: 10.1001/jama.2013.193.Buysse DJ. Insomnia. JAMA. 2013 Feb 20;309(7):706–16. DOI: 10.1001/jama.2013.193.Агальцов М.В. Обзор результатов международных клинических исследований применения препарата пролонгированного мелатонина (Циркадин) при нарушениях сна // Эффективная фармакотерапия. 2013. № 6 (12). С. 38–44.Agal’tsov MV. An overview of the results of international clinical trials of the sustainedrelease melatonin (Circadin) for sleep disorders. Effektivnaya farmakoterapiya. (Suppl. «Son i ego rasstroistva»). 2013;(12): 38–46. (In Russ.)Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J. Psychopharmacol. 2010 Nov;24(11):1577–601. DOI: 10.1177/0269881110379307Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J. Psychopharmacol. 2010 Nov;24(11):1577–601. DOI: 10.1177/0269881110379307Hughes RJ, Sack RL, Lewy AJ. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep. 1998;21(1):52–68. PMID: 9485533.Hughes RJ, Sack RL, Lewy AJ. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep. 1998;21(1):52–68. PMID: 9485533.Leger D, Laudon M, Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am. J. Med. 2004 Jan 15;116(2):91–5. DOI: 10.1016/j.amjmed.2003.07.017Leger D, Laudon M, Zisapel N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am. J. Med. 2004 Jan 15;116(2):91–5. DOI: 10.1016/j.amjmed.2003.07.017Ellis CM, Lemmens G, Parkes JD. Melatonin and insomnia. J. Sleep. Res. 1996 Mar;5(1):61-–5. DOI: 10.1046/j.1365–2869.1996.00003.xEllis CM, Lemmens G, Parkes JD. Melatonin and insomnia. J. Sleep. Res. 1996 Mar;5(1):61-–5. DOI: 10.1046/j.1365–2869.1996.00003.xПолуэктов М. Г., Левин Я.И., Бойко А.Н. и др. Результаты российского мультицентрового исследования эффективности и безопасности мелаксена (мелатонин) для лечения нарушений сна у пациентов с хронической церебральной сосудистой недостаточностью // Журнал неврологии и психиатрии им. С.С. Корсакова. 2012. Т. 112. № 9. С. 26–31.Poluéktov MG, Levin IaI, Boĭko AN, Skoromets AA, Bel’skaia GN, Gustov AV, Doronin BM, Poverennova IE, Spirin NN, Iakupov EZ. [The results of Russian multicenter open-label observational study of the efficacy and safety of мelaxen (melatonin) for the treatment of disordered sleep in patients with chronic cerebral ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(9):26–31.Ochoa-Sanchez R, Comai S, Lacoste B, Bambico FR, Dominguez-Lopez S, Spadoni G, Rivara S, Bedini A, Angeloni D, Fraschini F, Mor M, Tarzia G, Descarries L, Gobbi G. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. J. Neurosci. 2011 Dec 14;31(50):18439–52. DOI: 10.1523/JNEUROSCI.2676–11.2011Ochoa-Sanchez R, Comai S, Lacoste B, Bambico FR, Dominguez-Lopez S, Spadoni G, Rivara S, Bedini A, Angeloni D, Fraschini F, Mor M, Tarzia G, Descarries L, Gobbi G. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. J. Neurosci. 2011 Dec 14;31(50):18439–52. DOI: 10.1523/JNEUROSCI.2676–11.2011Liu C., Weaver D. R., Jin X., Shearman L. P., Pieschl R. L., Gribkoff V. K., Reppert S.M. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron. 1997;19:91–102. DOI: 10.1016/S0896–6273(00)80350–5Liu C., Weaver D. R., Jin X., Shearman L. P., Pieschl R. L., Gribkoff V. K., Reppert S.M. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron. 1997;19:91–102. DOI: 10.1016/S0896–6273(00)80350–5Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br.J. Pharmacol. 2018;175:3190–3199. DOI: 10.1111/bph.14116Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br.J. Pharmacol. 2018;175:3190–3199. DOI: 10.1111/bph.14116Amaral F.G.D., Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch. Endocrinol. Metab. 2018;62:472–479. DOI: 10.20945/2359–3997000000066Amaral F.G.D., Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch. Endocrinol. Metab. 2018;62:472–479. DOI: 10.20945/2359–3997000000066Huysmans S, De Hert M, Desplenter F. Melatonine en slaapstoornissen: literatuuroverzicht en toetsing aan de psychiatrische praktijk [Melatonin and sleep disorders: Overview of literature and testing in psychiatric practice]. Tijdschr Psychiatr. 2019;61(12):854–861. Dutch. PMID: 31907900.Huysmans S, De Hert M, Desplenter F. Melatonine en slaapstoornissen: literatuuroverzicht en toetsing aan de psychiatrische praktijk [Melatonin and sleep disorders: Overview of literature and testing in psychiatric practice]. Tijdschr Psychiatr. 2019;61(12):854–861. Dutch. PMID: 31907900.Riha R.L. The use and misuse of exogenous melatonin in the treatment of sleep disorders. Curr. Opin. Pulm. Med. 2018;24:543–548. DOI: 10.1097/MCP.0000000000000522.Riha R.L. The use and misuse of exogenous melatonin in the treatment of sleep disorders. Curr. Opin. Pulm. Med. 2018;24:543–548. DOI: 10.1097/MCP.0000000000000522.Luthringer R, Muzet M, Zisapel N, Staner L. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia. Int Clin Psychopharmacol. 2009 Sep;24(5):239–49. DOI: 10.1097/YIC.0b013e32832e9b08Luthringer R, Muzet M, Zisapel N, Staner L. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia. Int Clin Psychopharmacol. 2009 Sep;24(5):239–49. DOI: 10.1097/YIC.0b013e32832e9b08Kryger’s Principles and Practice of Sleep Medicine. By Meir H. Kryger, Thomas Roth, Cathy A Goldstein. Elsevier Health Sciences, 2021. 2240 pp.Kryger’s Principles and Practice of Sleep Medicine. By Meir H. Kryger, Thomas Roth, Cathy A Goldstein. Elsevier Health Sciences, 2021. 2240 pp.Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep. 2011 Nov 1;34(11):1487–92. DOI: 10.5665/sleep.1382Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep. 2011 Nov 1;34(11):1487–92. DOI: 10.5665/sleep.1382Plog BA, Nedergaard M. The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future. Annu. Rev. Pathol. 2018 Jan 24;13:379–394. DOI: 10.1146/annurev-pathol051217–111018Plog BA, Nedergaard M. The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future. Annu. Rev. Pathol. 2018 Jan 24;13:379–394. DOI: 10.1146/annurev-pathol051217–111018León J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J. Pineal. Res. 2005 Jan;38(1):1–9. DOI: 10.1111/j.1600–079X.2004.00181.xLeón J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J. Pineal. Res. 2005 Jan;38(1):1–9. DOI: 10.1111/j.1600–079X.2004.00181.xLuboshitzky R, Shen-Orr Z, Tzischichinsky O, Maldonado M, Herer P, Lavie P. Actigraphic sleep-wake patterns and urinary 6-sulfatoxymelatonin excretion in patients with Alzheimer’s disease. Chronobiol. Int. 2001 May;18(3):513–24. DOI: 10.1081/cbi100103973Luboshitzky R, Shen-Orr Z, Tzischichinsky O, Maldonado M, Herer P, Lavie P. Actigraphic sleep-wake patterns and urinary 6-sulfatoxymelatonin excretion in patients with Alzheimer’s disease. Chronobiol. Int. 2001 May;18(3):513–24. DOI: 10.1081/cbi100103973Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp. Mol. Med. 2015 Mar 13;47(3): e148. DOI: 10.1038/emm.2014.121Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp. Mol. Med. 2015 Mar 13;47(3): e148. DOI: 10.1038/emm.2014.121Cardinali DP, Vigo DE, Olivar N, Vidal MF, Brusco LI. Melatonin Therapy in Patients with Alzheimer’s Disease. Antioxidants (Basel). 2014 Apr 10;3(2):245–77. DOI: 10.3390/antiox3020245Cardinali DP, Vigo DE, Olivar N, Vidal MF, Brusco LI. Melatonin Therapy in Patients with Alzheimer’s Disease. Antioxidants (Basel). 2014 Apr 10;3(2):245–77. DOI: 10.3390/antiox3020245Wang YY, Zheng W, Ng CH, Ungvari GS, Wei W, Xiang YT. Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer’s disease. Int J Geriatr Psychiatry. 2017 Jan;32(1):50–57. DOI: 10.1002/gps.4571Wang YY, Zheng W, Ng CH, Ungvari GS, Wei W, Xiang YT. Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer’s disease. Int J Geriatr Psychiatry. 2017 Jan;32(1):50–57. DOI: 10.1002/gps.4571Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013 May 17;8(5): e63773. DOI: 10.1371/journal.pone.0063773Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013 May 17;8(5): e63773. DOI: 10.1371/journal.pone.0063773Andersen LP, Gögenur I, Rosenberg J, Reiter RJ. The Safety of Melatonin in Humans. Clin. Drug. Investig. 2016 Mar;36(3):169–75. DOI: 10.1007/s40261–015–0368–5Andersen LP, Gögenur I, Rosenberg J, Reiter RJ. The Safety of Melatonin in Humans. Clin. Drug. Investig. 2016 Mar;36(3):169–75. DOI: 10.1007/s40261–015–0368–5Li T, Jiang S, Han M, Yang Z, Lv J, Deng C, Reiter RJ, Yang Y. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Front Neuroendocrinol. 2019 Jan;52:22–28. DOI: 10.1016/j.yfrne.2018.06.004Li T, Jiang S, Han M, Yang Z, Lv J, Deng C, Reiter RJ, Yang Y. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Front Neuroendocrinol. 2019 Jan;52:22–28. DOI: 10.1016/j.yfrne.2018.06.004Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2022 Jan;269(1):205–216. DOI: 10.1007/s00415–020–10381-wFatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2022 Jan;269(1):205–216. DOI: 10.1007/s00415–020–10381-wДиагностика и лечение нарушение сна /учебно-методическое пособие / Всероссийский центр экстренной и радиационной медицины им. А.М. Никифорова МЧС России. СПб.: ООО «НПО ПБ АС», 2020. 52 с.Diagnosis and treatment of sleep disorders / teaching aid / All-Russian Center for Emergency and Radiation Medicine. A.M. Nikiforov EMERCOM of Russia. St. Petersburg: NPO PB AS LLC, 2020. 52 p.McDonagh MS, Holmes R, Hsu F. Pharmacologic Treatments for Sleep Disorders in Children: A Systematic Review. J. Child. Neurol. 2019 Apr;34(5):237–247. DOI: 10.1177/0883073818821030McDonagh MS, Holmes R, Hsu F. Pharmacologic Treatments for Sleep Disorders in Children: A Systematic Review. J. Child. Neurol. 2019 Apr;34(5):237–247. DOI: 10.1177/0883073818821030Мусина Н.З., Аляутдин Р.Н., Романов Б.К., Родионов О.Н. Коррекция биоритмов мелатонином у летного состава // Росс. мед. журнал. 2005. № 6. С. 37–39.Musina N.Z., Alyautdin R.N., Romanov B.K., Rodionov O.N. Correction of biorhythms by melatonin in flight personnel // Ross. honey. magazine. 2005. No. 6. P. 37–39.Мендель В.Э., Мендель О.И. Мелатонин: роль в организме и терапевтические возможности. Опыт применения препарата Мелаксен вроссийской медицинской практике // РМЖ. 2010;6:336. http://www.rmj.ru/articles/terapiya/Melatonin_roly_v_organizme_i_terapevticheskie__vozmoghnosti_Opyt_primeneniya_preparata_Melaksen__v_rossiyskoy_medicinskoy_praktike/#ixzz7kt6Vlh6DMendel V.A., Mendel O.I. Melatonin: role in the body and therapeutic. The experience of the drug Melaxen in the Russian medical practice, Russian medical journal. 2010. Vol. 18, N6. P. 336–341. https://www.researchgate.net/publication/288834949_W_Mendel_O_Mendel_Experience_of_application_of_Melaxen_in_the_Russian_medical_practice_Russian_Medical_Journal_volume_18_number_4_2010_Conclusions_Clinical_Research_in_Russian_clinics_confirmed_the_efComperatore CA, Lieberman HR, Kirby AW, Adams B, Crowley JS. Melatonin efficacy in aviation missions requiring rapid deployment and night operations. Aviat. Space. Environ. Med. 1996 Jun;67(6):520–4.Comperatore CA, Lieberman HR, Kirby AW, Adams B, Crowley JS. Melatonin efficacy in aviation missions requiring rapid deployment and night operations. Aviat. Space. Environ. Med. 1996 Jun;67(6):520–4.Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, Ruotsalainen JH. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database Syst. Rev. 2014 Aug 12;(8): CD009776. DOI: 10.1002/14651858.CD009776.pub2. PMID: 25113164.Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, Ruotsalainen JH. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database Syst. Rev. 2014 Aug 12;(8): CD009776. DOI: 10.1002/14651858.CD009776.pub2. PMID: 25113164.Mostafavi SA, Akhondzadeh S, Mohammadi MR, Keshtkar AA, Hosseini S, Eshraghian MR, Motlagh TA, Alipour R, Keshavarz SA. Role of Melatonin in Body Weight: A Systematic Review and Meta-Analysis. Curr. Pharm. Des. 2017;23(23):3445–3452. DOI: 10.2174/1381612822666161129145618Mostafavi SA, Akhondzadeh S, Mohammadi MR, Keshtkar AA, Hosseini S, Eshraghian MR, Motlagh TA, Alipour R, Keshavarz SA. Role of Melatonin in Body Weight: A Systematic Review and Meta-Analysis. Curr. Pharm. Des. 2017;23(23):3445–3452. DOI: 10.2174/1381612822666161129145618Bacaro V., Ballesio A., Cerolini S., Vacca M., Poggiogalle E., Donini L.M., Lucidi F., Lombardo C. Sleep duration and obesity in adulthood: An updated systematic review and meta-analysis. Obes. Res. Clin. Pract. 2020;14:301–309. DOI: 10.1016/j.orcp.2020.03.004Bacaro V., Ballesio A., Cerolini S., Vacca M., Poggiogalle E., Donini L.M., Lucidi F., Lombardo C. Sleep duration and obesity in adulthood: An updated systematic review and meta-analysis. Obes. Res. Clin. Pract. 2020;14:301–309. DOI: 10.1016/j.orcp.2020.03.004Shih D.P., Lin P.Y., Liang W.M., Tseng P.C., Kuo H.W., Wang J.Y. Sleep duration and effort-reward imbalance (ERI) associated with obesity and type II diabetes mellitus (T2DM) among Taiwanese middle-aged public servants. Int. J. Environ. Res. Public Health. 2020;17:6577. DOI: 10.3390/ijerph17186577Shih D.P., Lin P.Y., Liang W.M., Tseng P.C., Kuo H.W., Wang J.Y. Sleep duration and effort-reward imbalance (ERI) associated with obesity and type II diabetes mellitus (T2DM) among Taiwanese middle-aged public servants. Int. J. Environ. Res. Public Health. 2020;17:6577. DOI: 10.3390/ijerph17186577Lao X.Q., Liu X., Deng H.B., Chan T.C., Ho K. F., Wang F., Vermeulen R., Tam T., Wong M.C.S., Tse L.A., et al. Sleep quality, sleep duration, and the risk of coronary heart disease: A prospective cohort study with 60,586 adults. J. Clin. Sleep Med. 2018;14:109–117. DOI: 10.5664/jcsm.6894Lao X.Q., Liu X., Deng H.B., Chan T.C., Ho K. F., Wang F., Vermeulen R., Tam T., Wong M.C.S., Tse L.A., et al. Sleep quality, sleep duration, and the risk of coronary heart disease: A prospective cohort study with 60,586 adults. J. Clin. Sleep Med. 2018;14:109–117. DOI: 10.5664/jcsm.6894St-Onge M.P. Sleep-obesity relation: Underlying mechanisms and consequences for treatment. Obes. Rev. 2017;18(Suppl. S1):34–39. DOI: 10.1111/obr.12499St-Onge M.P. Sleep-obesity relation: Underlying mechanisms and consequences for treatment. Obes. Rev. 2017;18(Suppl. S1):34–39. DOI: 10.1111/obr.12499Suriagandhi V., Nachiappan V. Protective effects of melatonin against obesity-induced by leptin resistance. Behav. Brain Res. 2021;417:113598. DOI: 10.1016/j.bbr.2021.113598Suriagandhi V., Nachiappan V. Protective effects of melatonin against obesity-induced by leptin resistance. Behav. Brain Res. 2021;417:113598. DOI: 10.1016/j.bbr.2021.113598Sharma R., Sahota P., Thakkar M.M. Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus. J. Pineal Res. 2018;65: e12498. DOI: 10.1111/jpi.12498Sharma R., Sahota P., Thakkar M.M. Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus. J. Pineal Res. 2018;65: e12498. DOI: 10.1111/jpi.12498Gombert M., Martin-Carbonell V., Pin-Arboledas G., Carrasco-Luna J., Carrasco-García Á., Codoñer-Franch P. Melatonin levels in children with obesity are associated with metabolic risk and inflammatory parameters. Nutrients. 2021;13:3629. DOI: 10.3390/nu13103629Gombert M., Martin-Carbonell V., Pin-Arboledas G., Carrasco-Luna J., Carrasco-García Á., Codoñer-Franch P. Melatonin levels in children with obesity are associated with metabolic risk and inflammatory parameters. Nutrients. 2021;13:3629. DOI: 10.3390/nu13103629Xu P.F., Wang J.L., Hong F., Wang S., Jin X., Xue T.T., Jia L., Zhai Y.G. Melatonin prevents obesity through modulation of gut microbiota in mice. J. Pineal Res. 2017;62: e12399. doi: 10.1111/jpi.12399Xu P.F., Wang J.L., Hong F., Wang S., Jin X., Xue T.T., Jia L., Zhai Y.G. Melatonin prevents obesity through modulation of gut microbiota in mice. J. Pineal Res. 2017;62: e12399. doi: 10.1111/jpi.12399Gao T., Wang Z., Dong Y., Cao J., Lin R., Wang X., Yu Z., Chen Y. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice. J. Pineal Res. 2019;67: e12574. DOI: 10.1111/jpi.12574Gao T., Wang Z., Dong Y., Cao J., Lin R., Wang X., Yu Z., Chen Y. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice. J. Pineal Res. 2019;67: e12574. DOI: 10.1111/jpi.12574Simonneaux V., Pevet P. (2006). Neuropeptides and Photoperiodic Regulation of Melatonin Synthesis. Annals of the New York Academy of Sciences. 839. 284–287. DOI: 10.1111/j.1749–6632.1998.tb10776.xSimonneaux V., Pevet P. (2006). Neuropeptides and Photoperiodic Regulation of Melatonin Synthesis. Annals of the New York Academy of Sciences. 839. 284–287. DOI: 10.1111/j.1749–6632.1998.tb10776.xKazula A, Nowak JZ, Iuvone PM. Regulation of melatonin and dopamine biosynthesis in chick retina: the role of GABA. Vis Neurosci. 1993 Jul-Aug;10(4):621–9. DOI: 10.1017/s0952523800005320Kazula A, Nowak JZ, Iuvone PM. Regulation of melatonin and dopamine biosynthesis in chick retina: the role of GABA. Vis Neurosci. 1993 Jul-Aug;10(4):621–9. DOI: 10.1017/s0952523800005320Chase MH, Soja PJ, Morales FR. Evidence that glycine mediates the postsynaptic potentials that inhibit lumbar motoneurons during the atonia of active sleep. J. Neurosci. 1989 Mar;9(3):743–51. DOI: 10.1523/JNEUROSCI.09–03–00743.1989Chase MH, Soja PJ, Morales FR. Evidence that glycine mediates the postsynaptic potentials that inhibit lumbar motoneurons during the atonia of active sleep. J. Neurosci. 1989 Mar;9(3):743–51. DOI: 10.1523/JNEUROSCI.09–03–00743.1989Curtis DR, Hösli L, Johnston GA. Inhibition of spinal neurons by glycine. Nature. 1967 Sep 30;215(5109):1502–3. DOI: 10.1038/2151502a0. PMID: 4293850.Curtis DR, Hösli L, Johnston GA. Inhibition of spinal neurons by glycine. Nature. 1967 Sep 30;215(5109):1502–3. DOI: 10.1038/2151502a0. PMID: 4293850.Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J. Pharmacol. Sci. 2012;118(2):145–8. DOI: 10.1254/jphs.11r04fmBannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J. Pharmacol. Sci. 2012;118(2):145–8. DOI: 10.1254/jphs.11r04fmBannai M, Kawai N, Nagao K, Nakano S, Matsuzawa D, Shimizu E. Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats. Psychiatry Clin. Neurosci. 2011 Mar;65(2):142–9. DOI: 10.1111/j.1440–1819.2010.02181.xBannai M, Kawai N, Nagao K, Nakano S, Matsuzawa D, Shimizu E. Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats. Psychiatry Clin. Neurosci. 2011 Mar;65(2):142–9. DOI: 10.1111/j.1440–1819.2010.02181.xLynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology. 2009 Jan;56(1):303–9. DOI: 10.1016/j.neuropharm.2008.07.034Lynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology. 2009 Jan;56(1):303–9. DOI: 10.1016/j.neuropharm.2008.07.034Инструкция по медицинскому применению лекарственного препарата, рег. номер: ЛП 007897.Инструкция по медицинскому применению лекарственного препарата, рег. номер: ЛП 007897.Mathur Р, Rana А, Saroha К, Mathur К. Sublingual Route: An Approach to Administered Drugsin Systemic Circulation. Int J Pharma Res Health Sci. 2019; 7 (1): 2869–73. doi: 10.21276/ijprhs.2019.01.01.Mathur Р, Rana А, Saroha К, Mathur К. Sublingual Route: An Approach to Administered Drugsin Systemic Circulation. Int J Pharma Res Health Sci. 2019; 7 (1): 2869–73. doi: 10.21276/ijprhs.2019.01.01.Инструкция по медицинскому применению лекарственного препарата, рег. номер: ЛП 005295.Инструкция по медицинскому применению лекарственного препарата, рег. номер: ЛП 005295.

The authors declare that there are no conflicts of interest present.